Skip to main navigation Skip to search Skip to main content

Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study

  • Daniel Peterson
  • , Mark Van Poppel
  • , Warren Boling
  • , Perry Santos
  • , Jason Schwalb
  • , Howard Eisenberg
  • , Ashesh Mehta
  • , Heather Spader
  • , James Botros
  • , Frank D. Vrionis
  • , Andrew Ko
  • , P. David Adelson
  • , Bradley Lega
  • , Peter Konrad
  • , Guillermo Calle
  • , Fernando L. Vale
  • , Richard Bucholz
  • , R. Mark Richardson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number8
JournalBioelectronic Medicine
Volume10
Issue number1
DOIs
StatePublished - Dec 2024

ASJC Scopus Subject Areas

  • Medicine (miscellaneous)
  • Biomedical Engineering
  • Computer Science Applications

Keywords

  • Inflammatory reflex
  • Neuroimmune modulation
  • Rheumatoid arthritis
  • Vagus nerve stimulation

Cite this